VC-01™
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for VC-01™, covering 2022-03-24 to 2023-10-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus [Phase 1, Phase 2]